Skip to main content
PepStack
Blutwerte · Marker

Erythrozyten

Red Blood Cells · RBC · Rote Blutkörperchen

BlutbildZeitabhängig
Einheit:
x10^12/L
Abbreviation
RBC

The test quantifies the concentration of red blood cells in the blood.

Reference Ranges

Reference
4.55.9x10^12/L
4.5
5.9
LowNormalHigh
Reference
Unit · x10^12/L

Reference ranges can vary slightly based on age and sex. Typically higher in males.

Overview

Übersicht

Erythrozyten, or red blood cells (RBCs), are the most abundant cells in human blood, primarily responsible for transporting oxygen from the lungs to tissues and carbon dioxide from tissues back to the lungs. This biomarker measures the concentration of RBCs in the blood, reflecting the body's ability to maintain adequate oxygen delivery to tissues. Clinically, RBC count is crucial in diagnosing and managing various forms of anemia, polycythemia, and other hematologic disorders. Researchers observed that RBC morphology, including shape and size, can provide insights into different types of anemia, such as microcytic, normocytic, and macrocytic anemias, and help differentiate between causes like blood loss, marrow failure, and hemolysis. In the context of athletic performance and biohacking, RBC count is relevant as it can influence oxygen delivery and endurance. Athletes may seek to optimize RBC levels to enhance performance, while biohackers might focus on maintaining optimal levels for longevity and vitality. However, several factors can confound RBC measurements, including hydration status, altitude, and recent physical activity. Additionally, variations in RBC count can occur due to time of day and fasting status, necessitating standardized testing conditions for accurate interpretation.

Klinische Bedeutung

Elevated RBC levels may indicate conditions such as polycythemia vera or chronic hypoxia, while reduced levels are often seen in anemia, blood loss, or bone marrow disorders.

Dynamics

Trend Interpretation

Rising Values

Progressively rising RBC values may indicate polycythemia or adaptation to high altitude. Re-test in 4 weeks if outside optimal range.

Falling Values

Progressively falling RBC values suggest anemia or bone marrow suppression.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Dehydration
  • Polycythemia vera
  • Chronic hypoxia
  • High altitude
  • Smoking
Cause

Low Levels

  • Iron deficiency anemia
  • Chronic kidney disease
  • Bone marrow disorders
  • Hemolysis
  • Acute blood loss
Protocol

How to Optimize

Lever

Lifestyle

  • Regular aerobic exercise
  • Avoid smoking
  • Stay hydrated
Lever

Nutrition

  • Iron-rich foods
  • Vitamin B12 sources
  • Folate-rich foods
Lever

Supplementation

  • Iron supplements
  • Vitamin B12
  • Folic acid

Note:

Consult a physician before starting iron supplementation, especially if not iron deficient.

Testing Guidelines

Fasting Not Required
🕐Time-Sensitive

RBC count may vary slightly throughout the day; morning samples are preferred.

Testing Frequency

Annually for healthy adults, more frequently if managing a condition.

Interfering Factors

  • Recent intense exercise
  • Dehydration
  • Altitude changes

Related Peptides & Hormones

Erythropoietin

May affect

hormone or peptide

Open Research Questions

Current research suggests that the genetic underpinnings of red blood cell (RBC) metabolic heterogeneity and their implications for hemolysis remain incompletely understood, particularly regarding reference ranges and confounding factors such as diabetes and oxidative stress. Researchers have not yet established optimal targets for RBC morphology assessment in various anemias or the clinical significance of viscoelastic properties in disease states. Unanswered clinical questions include the precise mechanisms linking RBC dysfunction to diabetes complications and the role of genetic variants in transfusion outcomes.

21 Research Publications

508

Total Citations

5

Human/RCT

2.0

Avg. Influence

2026

Latest

Sort
Filter
#01

Red blood cell morphology.

ReviewInfluence6.0
218
This study examined the importance of red blood cell (RBC) morphology in diagnosing various types of anemia. Researchers found that abnormalities in RBC shape and features can provide critical diagnostic information, particularly in differentiating between thalassemia and other causes of anemia. Proper interpretation of RBC morphology can guide further clinical and laboratory follow-up.
View on PubMed
#02

Pathophysiology of Red Blood Cell Dysfunction in Diabetes and Its Complications.

ReviewInfluence1.0
59
Researchers investigated the relationship between red blood cell dysfunction and diabetes mellitus. The study found that chronic hyperglycemia leads to significant morphological and functional changes in RBCs, contributing to anemia and increased morbidity in diabetic patients. The findings highlight the complex interplay between RBC alterations and diabetes-related complications.
View on PubMed
#03

Technologies for measuring red blood cell deformability.

Review
40
This study reviewed technologies for measuring red blood cell (RBC) deformability, which is crucial for oxygen delivery. Researchers found that advancements in microfluidics have improved the sensitivity and throughput of these measurements, enabling better understanding of RBC behavior in various diseases.
View on PubMed
#04

Congenital Hemolytic Anemia.

UnknownInfluence1.0
29
Researchers studied congenital hemolytic anemias, which are characterized by the destruction of red blood cells due to intrinsic disorders. The study found that patients typically present with symptoms like pallor and jaundice, and laboratory features include anemia and elevated bilirubin levels. Treatment options vary, with some cases benefiting from splenectomy while others require supportive care.
View on PubMed
#05

Challenges for red blood cell biomarker discovery through proteomics.

Review
28
This review addressed the challenges in discovering red blood cell (RBC) biomarkers through proteomics. Researchers found that the unique characteristics of mature RBCs complicate the identification of functional proteins, which is essential for understanding various anemias and RBC-related disorders.
View on PubMed
#06

Towards manufactured red blood cells for the treatment of inherited anemia.

ReviewInfluence1.0
28
Researchers discussed the potential of manufactured red blood cells (RBCs) as a treatment for inherited anemias. They found that laboratory-grown RBCs could address compatibility issues in transfusions, with successful proof-of-principle mini-transfusions conducted. Ongoing trials aim to assess the equivalence of manufactured RBCs to natural donor RBCs.
View on PubMed
#07

Ferroptosis regulates hemolysis in stored murine and human red blood cells.

Animal, HumanInfluence1.0
23
This study explored the role of ferroptosis in the hemolysis of stored red blood cells. Researchers identified genetic factors that influence RBC metabolism and hemolysis, discovering a significant association between specific genetic variants and RBC iron content and lipid peroxidation. These findings may have implications for understanding hemolysis in blood donors.
View on PubMed
#08

A Systematic Review of Red Blood Cells Biomarkers in Human Aging.

Meta-Analysis
20
Researchers conducted a systematic review on the role of red blood cells (RBCs) as biomarkers of aging. They found that RBC indices change with age, and therapeutic interventions can potentially improve health outcomes for older adults. The review emphasizes the need for further investigation into RBC parameters related to aging.
View on PubMed
#09

Arginine metabolism is a biomarker of red blood cell and human aging.

Human
20
Researchers studied age-related changes in red blood cells, finding that arginine metabolism serves as a biomarker for aging. They observed increased arginine utilization in older individuals, which was consistent across different cohorts. The study linked these metabolic changes to RBC aging and potential implications for transfusion outcomes.
View on PubMed
#10

Autoimmune Hemolytic Anemia and Red Blood Cell Autoantibodies.

ReviewInfluence2.0
17
This review highlighted the challenges posed by autoimmune hemolytic anemia, where RBC autoantibodies destroy red blood cells. Researchers found that these autoantibodies complicate transfusion processes and can indicate underlying diseases. Understanding their clinical significance is essential for effective patient management.
View on PubMed

Publication Trend

Research publications about Erythrozyten over time

8total
1
'13
1
'17
2
'23
4
'24

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer